| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.41e-05 | 3 | 59 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell differentiation | 4.06e-05 | 134 | 59 | 5 | GO:0045639 | |
| GeneOntologyBiologicalProcess | ribosome-associated ubiquitin-dependent protein catabolic process | 1.67e-04 | 7 | 59 | 2 | GO:1990116 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.70e-04 | 288 | 59 | 6 | GO:0045637 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 1.80e-04 | 558 | 59 | 8 | GO:0030099 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 2.86e-04 | 9 | 59 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 2.86e-04 | 9 | 59 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.86e-04 | 9 | 59 | 2 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.57e-04 | 10 | 59 | 2 | GO:1903301 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 3.57e-04 | 10 | 59 | 2 | GO:0060397 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 3.57e-04 | 10 | 59 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 4.35e-04 | 11 | 59 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 4.35e-04 | 11 | 59 | 2 | GO:0070669 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 5.21e-04 | 12 | 59 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 5.21e-04 | 12 | 59 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 5.21e-04 | 12 | 59 | 2 | GO:0070672 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 6.15e-04 | 13 | 59 | 2 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 6.15e-04 | 13 | 59 | 2 | GO:0048541 | |
| GeneOntologyBiologicalProcess | mucociliary clearance | 6.15e-04 | 13 | 59 | 2 | GO:0120197 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 6.15e-04 | 13 | 59 | 2 | GO:0033131 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 6.15e-04 | 13 | 59 | 2 | GO:0045136 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 6.45e-04 | 59 | 59 | 3 | GO:0003351 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 7.16e-04 | 14 | 59 | 2 | GO:0046645 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 7.16e-04 | 14 | 59 | 2 | GO:1903299 | |
| GeneOntologyBiologicalProcess | extracellular transport | 7.46e-04 | 62 | 59 | 3 | GO:0006858 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 8.25e-04 | 15 | 59 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in prostate gland development | 8.25e-04 | 15 | 59 | 2 | GO:0060742 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.32e-04 | 8 | 61 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.71e-04 | 10 | 61 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 7.45e-04 | 14 | 61 | 2 | GO:0005642 | |
| Domain | STAT_TF_prot_interaction | 2.11e-04 | 7 | 60 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 2.11e-04 | 7 | 60 | 2 | IPR012345 | |
| Domain | STAT | 2.11e-04 | 7 | 60 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 2.11e-04 | 7 | 60 | 2 | IPR015988 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 2.11e-04 | 7 | 60 | 2 | IPR003529 | |
| Domain | - | 2.11e-04 | 7 | 60 | 2 | 2.60.40.630 | |
| Domain | GCC2_Rab_bind | 2.11e-04 | 7 | 60 | 2 | IPR032023 | |
| Domain | STAT_int | 2.11e-04 | 7 | 60 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.11e-04 | 7 | 60 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.11e-04 | 7 | 60 | 2 | PF02864 | |
| Domain | STAT_int | 2.11e-04 | 7 | 60 | 2 | PF02865 | |
| Domain | - | 2.11e-04 | 7 | 60 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.11e-04 | 7 | 60 | 2 | PF01017 | |
| Domain | Rab_bind | 2.11e-04 | 7 | 60 | 2 | PF16704 | |
| Domain | - | 2.11e-04 | 7 | 60 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_alpha | 2.81e-04 | 8 | 60 | 2 | IPR013800 | |
| Domain | HEMATOPO_REC_L_F2 | 2.81e-04 | 8 | 60 | 2 | PS01353 | |
| Domain | Glyco_transf_8 | 4.49e-04 | 10 | 60 | 2 | PF01501 | |
| Domain | Glyco_trans_8 | 4.49e-04 | 10 | 60 | 2 | IPR002495 | |
| Domain | - | 4.49e-04 | 10 | 60 | 2 | 1.10.220.60 | |
| Domain | Grip | 5.48e-04 | 11 | 60 | 2 | SM00755 | |
| Domain | GRIP | 5.48e-04 | 11 | 60 | 2 | PF01465 | |
| Domain | Ran_BP1 | 6.56e-04 | 12 | 60 | 2 | PF00638 | |
| Domain | GRIP_dom | 6.56e-04 | 12 | 60 | 2 | IPR000237 | |
| Domain | GRIP | 6.56e-04 | 12 | 60 | 2 | PS50913 | |
| Domain | RANBD1 | 6.56e-04 | 12 | 60 | 2 | PS50196 | |
| Domain | RanBD | 7.74e-04 | 13 | 60 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 7.74e-04 | 13 | 60 | 2 | IPR000156 | |
| Domain | TPR_repeat | 8.80e-04 | 133 | 60 | 4 | IPR019734 | |
| Domain | TPR-contain_dom | 1.37e-03 | 150 | 60 | 4 | IPR013026 | |
| Domain | TPR_REGION | 1.95e-03 | 165 | 60 | 4 | PS50293 | |
| Domain | TPR | 1.95e-03 | 165 | 60 | 4 | PS50005 | |
| Domain | - | 2.25e-03 | 81 | 60 | 3 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 2.85e-03 | 88 | 60 | 3 | IPR029044 | |
| Domain | - | 4.40e-03 | 207 | 60 | 4 | 1.25.40.10 | |
| Domain | Ig_E-set | 4.56e-03 | 104 | 60 | 3 | IPR014756 | |
| Domain | MAGE | 5.33e-03 | 34 | 60 | 2 | SM01373 | |
| Domain | MAGE | 5.96e-03 | 36 | 60 | 2 | PS50838 | |
| Domain | MAGE | 5.96e-03 | 36 | 60 | 2 | PF01454 | |
| Domain | MHD_dom | 5.96e-03 | 36 | 60 | 2 | IPR002190 | |
| Domain | TPR-like_helical_dom | 6.67e-03 | 233 | 60 | 4 | IPR011990 | |
| Domain | TPR | 8.27e-03 | 129 | 60 | 3 | SM00028 | |
| Domain | - | 1.00e-02 | 47 | 60 | 2 | 3.30.420.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.20e-05 | 17 | 38 | 3 | M47905 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.99e-05 | 25 | 38 | 3 | M41829 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 6.98e-05 | 30 | 38 | 3 | M41825 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 7.04e-05 | 5 | 38 | 2 | M49006 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 7.04e-05 | 5 | 38 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 7.04e-05 | 5 | 38 | 2 | M48986 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 8.14e-05 | 86 | 38 | 4 | MM15413 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.05e-04 | 6 | 38 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.05e-04 | 6 | 38 | 2 | MM15621 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 1.47e-04 | 7 | 38 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 1.47e-04 | 7 | 38 | 2 | M47430 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 1.47e-04 | 7 | 38 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 1.47e-04 | 7 | 38 | 2 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 1.47e-04 | 7 | 38 | 2 | M27907 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 2.52e-04 | 9 | 38 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 2.52e-04 | 9 | 38 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 2.52e-04 | 9 | 38 | 2 | M8066 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 3.14e-04 | 10 | 38 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 3.14e-04 | 10 | 38 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 3.14e-04 | 10 | 38 | 2 | MM15618 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 3.83e-04 | 11 | 38 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 3.83e-04 | 11 | 38 | 2 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 4.59e-04 | 12 | 38 | 2 | M27893 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 6.31e-04 | 14 | 38 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 6.31e-04 | 14 | 38 | 2 | M135 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 6.42e-04 | 63 | 38 | 3 | M635 | |
| Pathway | PID_IL4_2PATHWAY | 6.72e-04 | 64 | 38 | 3 | M28 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 7.27e-04 | 15 | 38 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 7.27e-04 | 15 | 38 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 7.27e-04 | 15 | 38 | 2 | M17681 | |
| Pathway | WP_FOXP3_IN_COVID19 | 7.27e-04 | 15 | 38 | 2 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 7.27e-04 | 15 | 38 | 2 | MM14536 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 7.76e-04 | 155 | 38 | 4 | M17411 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 8.29e-04 | 16 | 38 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 8.29e-04 | 16 | 38 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 8.29e-04 | 16 | 38 | 2 | M41733 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 8.29e-04 | 16 | 38 | 2 | MM15710 | |
| Pathway | WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME | 9.10e-04 | 71 | 38 | 3 | M39860 | |
| Pathway | WP_IL9_SIGNALING | 9.38e-04 | 17 | 38 | 2 | M39644 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.05e-03 | 18 | 38 | 2 | M673 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.05e-03 | 18 | 38 | 2 | MM1549 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.18e-03 | 19 | 38 | 2 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.18e-03 | 19 | 38 | 2 | M12836 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.30e-03 | 20 | 38 | 2 | MM15496 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 1.30e-03 | 20 | 38 | 2 | M39002 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.30e-03 | 20 | 38 | 2 | MM1389 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.58e-03 | 22 | 38 | 2 | M7747 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.59e-03 | 188 | 38 | 4 | MM15828 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.73e-03 | 23 | 38 | 2 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.73e-03 | 23 | 38 | 2 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.73e-03 | 23 | 38 | 2 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 1.73e-03 | 23 | 38 | 2 | M47904 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.88e-03 | 24 | 38 | 2 | M11520 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.88e-03 | 24 | 38 | 2 | M519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 2.04e-03 | 25 | 38 | 2 | M27865 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.04e-03 | 25 | 38 | 2 | MM1519 | |
| Pathway | WP_IL7_SIGNALING | 2.04e-03 | 25 | 38 | 2 | M39499 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 2.21e-03 | 26 | 38 | 2 | M39687 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.21e-03 | 26 | 38 | 2 | M27750 | |
| Pathway | PID_IL3_PATHWAY | 2.21e-03 | 26 | 38 | 2 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 2.21e-03 | 26 | 38 | 2 | MM15896 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.38e-03 | 27 | 38 | 2 | MM14712 | |
| Pathway | BIOCARTA_GH_PATHWAY | 2.38e-03 | 27 | 38 | 2 | M9043 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 2.44e-03 | 100 | 38 | 3 | MM15879 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 2.44e-03 | 100 | 38 | 3 | MM15826 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 2.56e-03 | 28 | 38 | 2 | M41724 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 2.74e-03 | 29 | 38 | 2 | M39616 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.74e-03 | 29 | 38 | 2 | M779 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 2.93e-03 | 30 | 38 | 2 | M234 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 3.13e-03 | 31 | 38 | 2 | M661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 3.13e-03 | 31 | 38 | 2 | M47964 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 3.33e-03 | 32 | 38 | 2 | M39333 | |
| Pathway | BIOCARTA_GH_PATHWAY | 3.54e-03 | 33 | 38 | 2 | MM1404 | |
| Pathway | PID_EPO_PATHWAY | 3.54e-03 | 33 | 38 | 2 | M233 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 3.54e-03 | 33 | 38 | 2 | MM15869 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 3.76e-03 | 34 | 38 | 2 | M48081 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.98e-03 | 35 | 38 | 2 | MM15144 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 4.21e-03 | 36 | 38 | 2 | M542 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 4.21e-03 | 36 | 38 | 2 | MM1418 | |
| Pathway | PID_GMCSF_PATHWAY | 4.21e-03 | 36 | 38 | 2 | M22 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 4.44e-03 | 37 | 38 | 2 | M8615 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 4.44e-03 | 37 | 38 | 2 | MM14564 | |
| Pathway | REACTOME_FLT3_SIGNALING | 4.68e-03 | 38 | 38 | 2 | M29803 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 4.68e-03 | 38 | 38 | 2 | M27536 | |
| Pathway | PID_ERBB4_PATHWAY | 4.68e-03 | 38 | 38 | 2 | M13 | |
| Pathway | PID_PDGFRB_PATHWAY | 5.00e-03 | 129 | 38 | 3 | M186 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 5.17e-03 | 40 | 38 | 2 | MM14945 | |
| Pathway | WP_IL5_SIGNALING | 5.17e-03 | 40 | 38 | 2 | M39392 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 5.43e-03 | 41 | 38 | 2 | MM15162 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 5.43e-03 | 41 | 38 | 2 | MM15200 | |
| Pathway | WP_IL2_SIGNALING | 5.69e-03 | 42 | 38 | 2 | M39536 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.69e-03 | 42 | 38 | 2 | MM15039 | |
| Pathway | PID_TCPTP_PATHWAY | 5.69e-03 | 42 | 38 | 2 | M91 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 5.96e-03 | 43 | 38 | 2 | MM15864 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.96e-03 | 43 | 38 | 2 | MM14609 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 5.96e-03 | 43 | 38 | 2 | M508 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 6.23e-03 | 44 | 38 | 2 | M1012 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 6.37e-03 | 277 | 38 | 4 | MM15414 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 6.51e-03 | 45 | 38 | 2 | M47408 | |
| Pubmed | Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. | 5.13e-09 | 3 | 61 | 3 | 18292815 | |
| Pubmed | Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer. | 2.05e-08 | 4 | 61 | 3 | 21464042 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 30930146 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23151802 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26999798 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 3.03e-06 | 2 | 61 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 3.03e-06 | 2 | 61 | 2 | 16775227 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 3.03e-06 | 2 | 61 | 2 | 31443474 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17447893 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12377952 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9524131 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 3.03e-06 | 2 | 61 | 2 | 21127177 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16289657 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25552366 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 3.03e-06 | 2 | 61 | 2 | 21431790 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16115927 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23275557 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28500076 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21826656 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11867689 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7720707 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 3.03e-06 | 2 | 61 | 2 | 15980098 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 3.03e-06 | 2 | 61 | 2 | 27264955 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15340066 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22159083 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20008792 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 33199496 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 3.03e-06 | 2 | 61 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 3.03e-06 | 2 | 61 | 2 | 12901872 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28074064 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 36755813 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16502315 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12217382 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 3.03e-06 | 2 | 61 | 2 | 12421978 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9852045 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31599926 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19966185 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21704724 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10594041 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21036145 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10486277 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 3.03e-06 | 2 | 61 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 3.03e-06 | 2 | 61 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 3.03e-06 | 2 | 61 | 2 | 30377054 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 3.03e-06 | 2 | 61 | 2 | 32790723 | |
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 3.03e-06 | 2 | 61 | 2 | 8732682 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18492722 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26717567 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10066807 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10835485 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35464049 | ||
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 3.03e-06 | 2 | 61 | 2 | 32281944 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 37277853 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 3.03e-06 | 2 | 61 | 2 | 23773921 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 3.03e-06 | 2 | 61 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 3.03e-06 | 2 | 61 | 2 | 24878107 | |
| Pubmed | Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice. | 3.03e-06 | 2 | 61 | 2 | 34818373 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12847485 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12835478 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 3.03e-06 | 2 | 61 | 2 | 24497979 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23465551 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11756158 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 3.03e-06 | 2 | 61 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 3.03e-06 | 2 | 61 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 3.03e-06 | 2 | 61 | 2 | 10486314 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 3.03e-06 | 2 | 61 | 2 | 24497923 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 29203513 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27367207 | ||
| Pubmed | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. | 3.03e-06 | 2 | 61 | 2 | 16493008 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24335105 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8816482 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 3.03e-06 | 2 | 61 | 2 | 29460051 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10851057 | ||
| Pubmed | Genome-wide regulation of electro-acupuncture on the neural Stat5-loss-induced obese mice. | 3.03e-06 | 2 | 61 | 2 | 28806763 | |
| Pubmed | Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells. | 3.03e-06 | 2 | 61 | 2 | 29105654 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17003334 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17438530 | ||
| Pubmed | Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. | 3.03e-06 | 2 | 61 | 2 | 15677477 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16757175 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15677453 | ||
| Pubmed | Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas. | 3.03e-06 | 2 | 61 | 2 | 15870688 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28606561 | ||
| Pubmed | Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. | 3.03e-06 | 2 | 61 | 2 | 19833766 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17317776 | ||
| Pubmed | Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. | 3.03e-06 | 2 | 61 | 2 | 20415542 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23332799 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 3.03e-06 | 2 | 61 | 2 | 12393407 | |
| Pubmed | [Effect of STAT5 gene silencing on the proliferation of T lymphocytes in a mouse model of asthma]. | 3.03e-06 | 2 | 61 | 2 | 22455944 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12039059 | ||
| Pubmed | The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. | 3.03e-06 | 2 | 61 | 2 | 32041920 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17976521 | ||
| GeneFamily | Glycosyltransferase family 8 | 2.67e-04 | 9 | 50 | 2 | 436 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN | 6.68e-06 | 53 | 60 | 4 | M8077 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 3.07e-06 | 167 | 60 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.20e-06 | 186 | 60 | 5 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-06 | 186 | 60 | 5 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.22e-06 | 193 | 60 | 5 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.25e-05 | 165 | 60 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.25e-05 | 165 | 60 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 167 | 60 | 4 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 167 | 60 | 4 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.13e-05 | 170 | 60 | 4 | 288014dedda8babc51fe08e48a55e68d83e1b1d2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.30e-05 | 176 | 60 | 4 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 180 | 60 | 4 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 181 | 60 | 4 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 181 | 60 | 4 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 181 | 60 | 4 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 181 | 60 | 4 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.04e-04 | 181 | 60 | 4 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.04e-04 | 181 | 60 | 4 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.04e-04 | 181 | 60 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.06e-04 | 182 | 60 | 4 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.06e-04 | 182 | 60 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 182 | 60 | 4 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.06e-04 | 182 | 60 | 4 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 183 | 60 | 4 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 60 | 4 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.08e-04 | 183 | 60 | 4 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 60 | 4 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-04 | 185 | 60 | 4 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 186 | 60 | 4 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 186 | 60 | 4 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.20e-04 | 188 | 60 | 4 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 188 | 60 | 4 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.20e-04 | 188 | 60 | 4 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 188 | 60 | 4 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.20e-04 | 188 | 60 | 4 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 189 | 60 | 4 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 189 | 60 | 4 | ebc16b8eab84167d74446783d7e802acedc6b9c6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 189 | 60 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.25e-04 | 190 | 60 | 4 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.25e-04 | 190 | 60 | 4 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 190 | 60 | 4 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 190 | 60 | 4 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.25e-04 | 190 | 60 | 4 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-04 | 190 | 60 | 4 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 190 | 60 | 4 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.30e-04 | 192 | 60 | 4 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 60 | 4 | 5890076929598e88fe9d59a4e4e858b446746ce9 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.30e-04 | 192 | 60 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.33e-04 | 193 | 60 | 4 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 193 | 60 | 4 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 1.33e-04 | 193 | 60 | 4 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.33e-04 | 193 | 60 | 4 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 193 | 60 | 4 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-04 | 193 | 60 | 4 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.33e-04 | 193 | 60 | 4 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.33e-04 | 193 | 60 | 4 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-04 | 194 | 60 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-04 | 194 | 60 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-04 | 194 | 60 | 4 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.35e-04 | 194 | 60 | 4 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.35e-04 | 194 | 60 | 4 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-04 | 194 | 60 | 4 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 194 | 60 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-04 | 194 | 60 | 4 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 1.38e-04 | 195 | 60 | 4 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 195 | 60 | 4 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 195 | 60 | 4 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 195 | 60 | 4 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 195 | 60 | 4 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 195 | 60 | 4 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 195 | 60 | 4 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 195 | 60 | 4 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.38e-04 | 195 | 60 | 4 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.41e-04 | 196 | 60 | 4 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 196 | 60 | 4 | 05b437af66cb43ba098ea93a02dc2f7430bf8c1b | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 196 | 60 | 4 | 009e83c7251cf300be78b263634d233a8d972a68 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-04 | 197 | 60 | 4 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.44e-04 | 197 | 60 | 4 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.44e-04 | 197 | 60 | 4 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-04 | 197 | 60 | 4 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.44e-04 | 197 | 60 | 4 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 199 | 60 | 4 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 199 | 60 | 4 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 199 | 60 | 4 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.52e-04 | 200 | 60 | 4 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.52e-04 | 200 | 60 | 4 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-04 | 200 | 60 | 4 | cf71c3f6281650940f3ade04ea62be3f340bfc68 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.52e-04 | 200 | 60 | 4 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 1.52e-04 | 200 | 60 | 4 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 84 | 60 | 3 | 52d167614afa9b056f2934142d3250fe5e70e806 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.52e-04 | 102 | 60 | 3 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.52e-04 | 102 | 60 | 3 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.52e-04 | 102 | 60 | 3 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| Disease | Hereditary motor and sensory neuropathy with optic atrophy | 1.22e-05 | 3 | 60 | 2 | cv:C0393807 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 4.99e-05 | 35 | 60 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | oleoyl-oleoyl-glycerol (18:1/18:1) [1] measurement | 6.07e-05 | 6 | 60 | 2 | EFO_0800497 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 9.57e-05 | 225 | 60 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | overall survival | 1.45e-04 | 9 | 60 | 2 | EFO_0000638 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.21e-04 | 11 | 60 | 2 | EFO_0800332 | |
| Disease | triacylglycerol 54:9 measurement | 2.65e-04 | 12 | 60 | 2 | EFO_0010427 | |
| Disease | alcohol and nicotine codependence | 3.13e-04 | 13 | 60 | 2 | EFO_0004776 | |
| Disease | Benign neoplasm of stomach | 5.42e-04 | 17 | 60 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.42e-04 | 17 | 60 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.42e-04 | 17 | 60 | 2 | C0154060 | |
| Disease | Malignant neoplasm of endometrium | 6.09e-04 | 18 | 60 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 6.09e-04 | 18 | 60 | 2 | C0346191 | |
| Disease | squamous cell carcinoma (is_marker_for) | 6.80e-04 | 19 | 60 | 2 | DOID:1749 (is_marker_for) | |
| Disease | haptoglobin measurement | 8.33e-04 | 21 | 60 | 2 | EFO_0004640 | |
| Disease | Stomach Carcinoma | 8.33e-04 | 21 | 60 | 2 | C0699791 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.71e-04 | 215 | 60 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | Inhalant adrenergic use measurement | 9.98e-04 | 96 | 60 | 3 | EFO_0009941 | |
| Disease | phosphatidylserines measurement | 1.00e-03 | 23 | 60 | 2 | EFO_0020049 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.13e-03 | 224 | 60 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.28e-03 | 26 | 60 | 2 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.49e-03 | 28 | 60 | 2 | DOID:3717 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HVLQHPKWPFKKKHD | 511 | Q5NDL2 | |
| HKHIKPWHKAKELIV | 1086 | Q8NDM7 | |
| IHAWEHLLLQPKTKG | 271 | Q6P2P2 | |
| NKKILHTAWHPKENI | 416 | P63151 | |
| PLNPKLWCHVHLKKS | 331 | Q9UIG0 | |
| CHLWHILEGKKLPKV | 491 | Q8IYT2 | |
| HGVKWLKAKHGNNQP | 151 | Q8IZP0 | |
| AAPKHLHKTPEGWLK | 781 | O94989 | |
| FKHLKKLLLVHGHWC | 1091 | O94823 | |
| LFWKPLSKLHANGKI | 451 | Q99650 | |
| LHGILKIIISWKKEH | 1186 | O94822 | |
| AKLPFVINDGKWHHI | 301 | Q15818 | |
| SHPAWLQKLSKHKTP | 21 | O43827 | |
| PKWNHLVHKFVIGHL | 191 | O95864 | |
| PHIQWIKHVEKNGSK | 286 | P21802 | |
| GFVAKLHKKEPQHWP | 256 | Q9HAY2 | |
| LAKLHKKDPQSWPFH | 1201 | Q9UJ55 | |
| QSLTPHWGHRLHLKK | 81 | Q6UW60 | |
| HWGHRLHLKKNPKVQ | 86 | Q6UW60 | |
| AKREKWIKHHPGEPL | 1181 | Q9Y4D7 | |
| WLLKNNPNKPKLCHH | 191 | P56597 | |
| LQEAKLLHWNGRHKP | 306 | Q9H1C3 | |
| VKAAKLLHWNGHLKP | 321 | Q68CQ7 | |
| VKHPDWLHKKLLEKN | 1161 | Q07864 | |
| LLHNAWKGKPSMIHS | 61 | Q8TDV0 | |
| VAQIIHQKPKLKDWH | 351 | Q92643 | |
| IKAHLWKPKGLAIAL | 51 | Q14973 | |
| LEPVLHKNLKNHSIW | 2446 | Q8NCM8 | |
| KIHKKHHEWTAPIGV | 201 | Q96IV6 | |
| LQLKGKKHVLHLWPK | 66 | Q9UKF2 | |
| HPCDNRNKGLKWLHK | 871 | Q7Z7M9 | |
| KCHTKKHNPRGTHLW | 196 | Q9NZC4 | |
| PELHLKHIGKTWAQL | 531 | Q99062 | |
| IHSHLWKGLQEKFLK | 46 | Q96JQ5 | |
| APGKWNDEHCLKKKH | 141 | P16109 | |
| KHARRHLSAKKLPNW | 446 | Q13118 | |
| KLPWKLLHAALHLMA | 76 | Q8NBI2 | |
| KRANKHKWVPLHLDV | 71 | Q659C4 | |
| GKKWLAGLLKHSAAL | 341 | Q5TDP6 | |
| FLHGKKWAASLPLLH | 1731 | Q9P2P1 | |
| ALPGIRKWLKQLFHH | 441 | P0DJD0 | |
| TLKKKRTWHKHGPGQ | 61 | O75151 | |
| ILIQWKKHGHPFVTK | 406 | Q96DL1 | |
| EKHGLQPALLVHWAK | 566 | P0DJD1 | |
| VPAGHNKWSKVRHIK | 56 | Q9BSH4 | |
| HLLHPTKGEPKWKAS | 166 | Q96NG3 | |
| LPKKQIHVWSGHTKG | 276 | O60508 | |
| LKKHLKPHWNDGAIL | 581 | P51692 | |
| HLDPIRENLGKHWKN | 586 | Q13546 | |
| GWSHKDLLRLSHLKP | 176 | P10155 | |
| LLAWTHKHPNNLKVA | 241 | O00764 | |
| LKKHHKPHWNDGAIL | 581 | P42229 | |
| HLHLFKKWKPIMKGP | 1971 | Q8N3C0 | |
| SLKLPHLKKAWGLQG | 346 | Q96M20 | |
| WQHLKKHVVPLPDGK | 591 | Q63HN8 | |
| LLLNLKIWKAPHVAK | 386 | P18577 | |
| LHKWSPKQIGEHLLL | 191 | Q96AG3 | |
| LHKSAAHLGKWQKLE | 346 | Q9NV64 | |
| WKLNQHKKIHTGEKP | 646 | A6NDX5 | |
| KKAQHKHWELAGTKL | 461 | Q92620 | |
| HHPKWKKKVASALGI | 216 | Q6P7N7 | |
| CLQKWHIENSKLPKH | 116 | Q6S9Z5 |